Glioblastoma survival in rural America: a 10-year experience from a quaternary care center - Takeaways - MDSpire

Glioblastoma survival in rural America: a 10-year experience from a quaternary care center

  • By

  • Pack, Emily

  • Cifarelli, Christopher P.

  • Bhatia, Sanjay

  • Lewis, Jeremy

  • Brandmeir, Nicholas

  • Gleckman, Aaron

  • Han, Peng Cheng

  • Wages, Nolan A.

  • Dotson, Timothy Shaun

  • Denney, Morgan W.

  • Wen, Sijin

  • Armistead, Matthew

  • Norouzi, Saeed

  • Aulakh, Sonikpreet

  • March 10, 2026

  • 0 min

Share

  • 1

    Glioblastoma (GBM) is the most common malignant brain tumor in adults, with a median overall survival of 10-13 months in real-world settings.

  • 2

    Rural patients face significant barriers to treatment, including long travel distances and lower access to specialized care, impacting survival outcomes.

  • 3

    Centralized neuro-oncology care may mitigate rural-urban disparities in GBM outcomes by ensuring uniform treatment protocols and access to resources.

  • 4

    The study analyzed 380 adults with IDH-WT GBM treated at WVU Ruby Memorial Hospital to evaluate survival differences based on treatment and demographics.

  • 5

    Findings suggest that adherence to standard treatment protocols is crucial for improving survival rates in GBM patients, particularly in rural areas.

Original Source(s)

Glioblastoma survival in rural America: a 10-year experience from a quaternary care center

  • by Pack, Emily, Cifarelli, Christopher P., Bhatia, Sanjay, Lewis, Jeremy, Brandmeir, Nicholas, Gleckman, Aaron, Han, Peng Cheng, Wages, Nolan A., Dotson, Timothy Shaun, Denney, Morgan W., Wen, Sijin, Armistead, Matthew, Norouzi, Saeed, Aulakh, Sonikpreet

  • March 10, 2026

Related Content

Uncommon Progression of BRAF/KRAS Wild-Type Colorectal Cancer: A Case Study of Cerebral Metastasis After Standard Treatment

CMRA-DETR: A Lightweight and High-Accuracy Detection Framework for MRI-Based Brain Tumor Identification

Evaluation of a 3D C-Vit Model for Enhanced Grading of Pediatric Brain Tumors: Interpretability and Performance Insights